Meyer, A. ., Horton, D. ., Neugebauer, N. ., Wooters, T. ., , Dwoskin, L. ., & Bardo, M. . (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033

Zhu, J. ., Bardo, M. ., Bruntz, R. ., Stairs, D. ., & Dwoskin, L. . (2007). Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression. The European Journal of Neuroscience, 26(3), 717-28. https://doi.org/10.1111/j.1460-9568.2007.05690.x

Dwoskin, L. ., Joyce, B. ., Zheng, G. ., Neugebauer, N. ., Manda, V. ., Lockman, P. ., … Crooks, P. . (2007). Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology, 74(8), 1271-82. https://doi.org/10.1016/j.bcp.2007.07.021 (Original work published 2007)

Zhu, J. ., Bardo, M. ., Green, T. ., Wedlund, P. ., & Dwoskin, L. . (2007). Nicotine increases dopamine clearance in medial prefrontal cortex in rats raised in an enriched environment. Journal of Neurochemistry, 103(6), 2575-88. https://doi.org/10.1111/j.1471-4159.2007.04951.x

Rahman, S. ., Zhang, Z. ., Papke, R. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2008). Region-specific effects of N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo. British Journal of Pharmacology, 153(4), 792-804. https://doi.org/10.1038/sj.bjp.0707612

Dwoskin, L. ., Wooters, T. ., Sumithran, S. ., Siripurapu, K. ., Joyce, B. ., Lockman, P. ., … Bardo, M. . (2008). N,N’-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal of Pharmacology and Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630

Rahman, S. ., Neugebauer, N. ., Zhang, Z. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2008). The novel nicotinic receptor antagonist N,N’-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens. European Journal of Pharmacology, 601(1-3), 103-5. https://doi.org/10.1016/j.ejphar.2008.10.037 (Original work published 2008)

Dwoskin, L. ., Pivavarchyk, M. ., Joyce, B. ., Neugebauer, N. ., Zheng, G. ., Zhang, Z. ., … Crooks, P. . Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 55, 31-63. https://doi.org/10.1007/978-0-387-78748-0_4 (Original work published 2009)